The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Clinical trial NCT07023861 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07023861
- Sponsor
- Affiliated Hospital of Jiangnan University
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-07-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.